Logo for SCYNEXIS Inc

SCYNEXIS Investor Relations Material

Latest events

Logo for SCYNEXIS Inc

Q4 2022 & Business Update

SCYNEXIS
Logo for SCYNEXIS

Q3 2024

18 Oct, 2024
Logo for SCYNEXIS

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from SCYNEXIS Inc

Access all reports
SCYNEXIS Inc. is a biotechnology company focused on the research, development, and commercialization of innovative therapies for fungal infections. The company's lead product, based on a novel antifungal platform, is designed to address severe and drug-resistant fungal infections in both hospital and outpatient settings. SCYNEXIS develops treatments for conditions with significant unmet medical needs, with a particular emphasis on antifungal agents targeting life-threatening infections. The company is headquartered in Jersey City, USA, and its shares are listed on the NASDAQ.